Digitalis purpurea" extract containing cardiac glycosides for the treatment of heart conditions was first described in the English-speaking medical literature by William Withering, in 1785, which is considered the beginning of modern therapeutics. It is used to increase cardiac contractility (it is a positive inotrope) and as an antiarrhythmic agent to control the heart rate, particularly in the irregular (and often fast) atrial fibrillation. Digitalis is hence often prescribed for patients in atrial fibrillation, especially if they have been diagnosed with congestive heart failure. Digoxin was approved for heart failure in 1998 under current regulations by the Food and Drug Administration
Where Do We Go from Here? (Chicago song) Where Do We Go from Here? (Chicago song) "Where Do We Go from Here?" is a song from the American rock band Chicago's second studio album, "Chicago" (1970). It was released as the B-side to the single "25 or 6 to 4", one of the leading songs off of the record. With that single, it went to number four on the Pop Singles chart in June 1970. The song was also the very first musical composition from bassist Peter Cetera, who was by this time contributing more than on the debut album released the year before. The song deals with